# HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/her2-low-breast-cancer-molecular-characteristics-and-prognosis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elisa Agostinetto,Mattia Rediti,Danai Fimereli,Véronique Debien,Martine Piccart,Philippe Aftimos,Christos Sotiriou,Evandro de Azambuja |
| Citations | 289 |
| DOI | 10.3390/cancers13112824 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2072-6694/13/11/2824/pdf?version=1622888113 |
| OpenAlex ID | https://openalex.org/W3166066183 |
| PMID | 34198891 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Philippe Aftimos](https://scholariq.org/researchers/philippe-aftimos/)

## Paper journal

- [Cancers](https://scholariq.org/journals/cancers/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.